Extracellular microRNA profiling for prognostic prediction in patients with high‐grade serous ovarian carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extracellular microRNA profiling for prognostic prediction in patients with high‐grade serous ovarian carcinoma
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 112, Issue 12, Pages 4977-4986
Publisher
Wiley
Online
2021-10-09
DOI
10.1111/cas.15154
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma
- (2021) Mayu Ukai et al. Cancers
- Predictive Relevance of Circulating miR-622 in Patients with Newly Diagnosed and Recurrent High-Grade Serous Ovarian Carcinoma
- (2020) Nicolas Vigneron et al. CLINICAL CHEMISTRY
- Serum miR-125b levels associated with epithelial ovarian cancer (EOC) development and treatment responses
- (2020) Zhonghua Chen et al. Bioengineered
- The clinical impact of intra‐ and extra‐cellular miRNAs in ovarian cancer
- (2020) Kosuke Yoshida et al. CANCER SCIENCE
- Utility of circulating serum miRNA profiles to evaluate the potential risk and severity of immune-mediated inflammatory disorders
- (2020) Rebeca Martínez-Hernández et al. JOURNAL OF AUTOIMMUNITY
- Evidence for liver and peripheral immune cells secreting tumor-suppressive extracellular vesicles in melanoma patients
- (2020) Jung-Hyun Lee et al. EBioMedicine
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer
- (2019) Guoying Jin et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Circulating microRNAs predict the response to anti-PD-1 therapy in non-small cell lung cancer
- (2019) Jinshuo Fan et al. GENOMICS
- Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab
- (2018) Ann Rita Halvorsen et al. ACTA ONCOLOGICA
- Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer
- (2018) Zuwei Li et al. BIOMEDICINE & PHARMACOTHERAPY
- microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer
- (2018) Divya Bhagirath et al. CANCER RESEARCH
- Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer
- (2018) Jaynish S. Shah et al. GYNECOLOGIC ONCOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients
- (2018) Dengbo Ji et al. EBioMedicine
- Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics
- (2018) Sotirios P. Fortis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A 5-MicroRNA Signature Identified from Serum MicroRNA Profiling Predicts Survival in Patients with Advanced Stage Non-Small Cell Lung Cancer
- (2018) Yajie Zhang et al. CARCINOGENESIS
- Integrated extracellular microRNA profiling for ovarian cancer screening
- (2018) Akira Yokoi et al. Nature Communications
- Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer
- (2017) Baoquan Liu et al. HUMAN PATHOLOGY
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer
- (2017) Akira Yokoi et al. Nature Communications
- A combination of circulating miRNAs for the early detection of ovarian cancer
- (2017) Akira Yokoi et al. Oncotarget
- MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1
- (2016) Ming Mao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Versatile roles of extracellular vesicles in cancer
- (2016) Nobuyoshi Kosaka et al. JOURNAL OF CLINICAL INVESTIGATION
- miR-187-5p Regulates Cell Growth and Apoptosis in Acute Lymphoblastic Leukemia via DKK2
- (2016) Ye Lou et al. ONCOLOGY RESEARCH
- MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3
- (2016) Hye Ree Kim et al. Oncotarget
- Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1 -Mutant Ovarian Cancer
- (2016) Young Eun Choi et al. Cell Reports
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
- (2010) Nobuyoshi Kosaka et al. CANCER SCIENCE
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started